相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension
Paul R. Forfia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography during routine care - A controlled study of 100 consecutive patients
Christophe Meune et al.
ARTHRITIS AND RHEUMATISM (2008)
Ambrisentan for the treatment of pulmonary arterial hypertension -: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
Nazzareno Galie et al.
CIRCULATION (2008)
Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension
M. J. Overbeek et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension
Liliana Moreno-Vinasco et al.
PHYSIOLOGICAL GENOMICS (2008)
Identification of candidate genes in scleroderma-related pulmonary arterial hypertension
Dmitry N. Grigoryev et al.
TRANSLATIONAL RESEARCH (2008)
High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis
Y. Allanore et al.
ARTHRITIS AND RHEUMATISM (2008)
Selective endothelinA receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease
Reda E. Girgis et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A meta-analysis of trials of pulmonary hypertension: A clinical condition looking for drugs and research methodology
Alejandro Macchia et al.
AMERICAN HEART JOURNAL (2007)
Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases
Peter Dorfmueller et al.
HUMAN PATHOLOGY (2007)
Right heart function and scleroderma: Insights from tricuspid annular plane systolic excursion
Chiu-Yen Lee et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2007)
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension
S. C. Mathai et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension
Lionel Schachna et al.
ARTHRITIS AND RHEUMATISM (2006)
Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension
Vallerie V. McLaughlin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension
M. M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions
C. P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Clinical differences between idiopathic and scleroderma-related pulmonary hypertension
Micah R. Fisher et al.
ARTHRITIS AND RHEUMATISM (2006)
Long term imatinib treatment in pulmonary arterial hypertension
R. Souza et al.
THORAX (2006)
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension
Karen C. Patterson et al.
ANNALS OF INTERNAL MEDICINE (2006)
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era
M. H. Williams et al.
HEART (2006)
Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension
Olivier Sanchez et al.
CHEST (2006)
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension
Mark H. Williams et al.
EUROPEAN HEART JOURNAL (2006)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Right heart function in scleroderma: Insights from myocardial Doppler tissue imaging
Shih-Hung Hsiao et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2006)
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension - A prospective, multicenter, open-label, 12-week trial
VF Tapson et al.
CHEST (2006)
Early detection of pulmonary arterial hypertension in systemic sclerosis -: A French nationwide prospective multicenter study
E Hachulla et al.
ARTHRITIS AND RHEUMATISM (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases
RE Girgis et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2005)
Imatinib for the treatment of pulmonary arterial hypertension
HA Ghofrani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
The right ventricle in pulmonary hypertension
KM Chin et al.
CORONARY ARTERY DISEASE (2005)
A study of the prevalence of systemic sclerosis in northeast England
RJ Allcock et al.
RHEUMATOLOGY (2004)
Sitaxsentan therapy for pulmonary arterial hypertension
RJ Barst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Endothelial dysfunction in pulmonary hypertension
R Budhiraja et al.
CIRCULATION (2004)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension
MM Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
End points and clinical trial designs in pulmonary arterial hypertension - Clinical and regulatory perspectives
MM Hoeper et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Clinical classification of pulmonary hypertension
G Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
End points in pulmonary arterial hypertension:: the way forward
A Peacock et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population
MD Mayes et al.
ARTHRITIS AND RHEUMATISM (2003)
Inflammation in pulmonary arterial hypertension
P Dorfmüller et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Systemic sclerosis: the susceptible host (genetics and environment)
FK Tan
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Scleroderma epidemiology
MD Mayes
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement
V Steen et al.
ARTHRITIS AND RHEUMATISM (2003)
Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis
SM Kawut et al.
CHEST (2003)
Age and risk of pulmonary arterial hypertension in scleroderma
L Schachna et al.
CHEST (2003)
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
D Mukerjee et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Emereing medical therapies for pulmonary arterial hypertension
N Galiè et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2002)
Survival in primary pulmonary hypertension - The impact of epoprostenol therapy
VV McLaughlin et al.
CIRCULATION (2002)
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension -: Prognostic factors and survival
O Sitbon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension - A double-blind, randomized, placebo-controlled trial
G Simonneau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
RN Channick et al.
LANCET (2001)
Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival
AJ MacGregor et al.
RHEUMATOLOGY (2001)
Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension -: Effect of prostacyclin therapy
S Eddahibi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
ZM Deng et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease -: A randomized, controlled trial
DB Badesch et al.
ANNALS OF INTERNAL MEDICINE (2000)
Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension - Comparison with cardiopulmonary exercise testing
S Miyamoto et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
分享论文
